It's hard for many to
accept that when it comes to investing, consistency of methodology is the
keenest way to build wealth. Nobody
knows for certain if the market will go up or down on any particular day. The capricious news-driven decline in stocks
last Wednesday certainly bears that out.
There was enough panic and concern to go around for everybody during,
and in the aftermath of, cable news' 24 hour analysis of Washington DC
political chaos. While my team attempts
as best as we can, we also don't know which stocks each day will outperform or
underperform, which sectors will advance and which will decline.
Market timing is simply
guesswork, and I try to avoid guessing if at all possible. The headlines on cable news and the internet
don't help much either. They serve,
instead, as distractions to the very nature of fundamental long-term investing.
To avoid disasters like
those one day calamities and other longer-term capitulations one needs to
shelve the "macho" and focus upon the macro view, irrespective of
exogenous noise or other siren songs.
Buying stocks and building diversification is not about distractions;
it's about fundamentals and good business practices. Companies that increase sales, develop
innovative solutions to the predicament of the human condition, build market
share and show accelerating bottom-line productivity year-over-year are
typically the kind of data generators that qualify as high relative strength
candidates in our portfolio-building process.
No matter what happens
to the conventional "stock averages" each day, our focus is upon
consistent leadership and overweighting those factors in our allocation models.
Reality
or fantasy
Within my quantitative
portfolio disciplines real, enduring portfolio gains are predominantly a factor
of 4 important components: (1) time (2) asset allocation (3) a "sell"
discipline (4) pricing power.
Is it really that
simple?
Mostly.
As with everything else
these days, conversation about the financial markets has become highly
politicized. Make no mistake, fiscal
policy and political persuasion do play important roles in the near-term vector
of market trajectory. One might even
extrapolate further by suggesting that their impact upon corporate governance,
earnings creation, and capital expenditures plays a unique part in our
analysis. But, as pointed out earlier,
one must be careful about inferring a direct
correlation between these micro
daily events and the broader swath of the economy's path and, by implication,
its impact upon your overall strategic risk/reward calculations regarding your
personal net-worth.
The key is obviously to
be fiscally responsible, allocate the proper weightings to these data, and to
be nimble enough to deflect whatever obstacles might interfere with your
financial objectives.
Principles of
portfolio-building emanate out of rudiments and scientific method. There are no shortcuts or high-risk gambits
that pay off all the time. It is nearly
impossible on this single page to illuminate all the permutations that science
imposes upon practical portfolio discipline.
But suffice it to say that wasting time looking for the "big
score" is probably the most useless of your tasks if you wish seriously to
succeed as a portfolio manager. I have
great empathy for the desire to do so, but very little sympathy.
More importantly,
though, is to break the cycle of "betting it all on red”.
Managing risk is just
like everything else in life: weighing the cost versus the benefit. Unless you already have large sums to lose,
it is not worth it to put all your eggs in one (biotech) basket. And besides, even the wealthy allocate a portion of their risk capital. Very rarely do you hear of an ultra-rich
entrepreneur betting his entire fortune on one golden opportunity.
Market fundamentals are
not a secret. They are known by amateur
and professional alike and typically sourced from the same data resources. What constitutes the difference is how those
with a steadier discipline apply that data towards becoming better informed and
more maneuverable at their craft.